Open | - |
Close | - |
Volume / Avg. | 29.703K / 624.411K |
Day Range | - - - |
52 Wk Range | 0.507 - 14.500 |
Market Cap | $1.657M |
P/E Ratio | 0.076 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 7.19% |
Days to Cover | 2.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agile Therapeutics (NASDAQ: AGRX) through any online brokerage.
Other companies in Agile Therapeutics’s space includes: Processa Pharma (NASDAQ:PCSA), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on Monday, March 18, 2024. The analyst firm set a price target for 0.00 expecting AGRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Agile Therapeutics (NASDAQ: AGRX) is $0.559 last updated Today at March 19, 2024 at 8:47 AM EDT.
There are no upcoming dividends for Agile Therapeutics.
Agile Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Agile Therapeutics.
Agile Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.